Douglas Drysdale
Chief Executive Officer at CYBIN INC.
Net worth: 13 148 $ as of 2024-04-29
Profile
Douglas L.
Drysdale currently works at Pernix Manufacturing LLC, as Chief Executive Officer & Director, Cybin Corp., as Chief Executive Officer from 2020, Cybin, Inc., as Chief Executive Officer from 2020, Cybin IRL Ltd., as Chief Executive Officer, SpineThera, Inc., as Director from 2022, and Adelia Therapeutics, Inc., as Director.
Mr. Drysdale also formerly worked at Norwich Pharmaceuticals, Inc., as Chief Executive Officer, Pernix Therapeutics Holdings, Inc., as Chairman, President & Chief Executive Officer from 2014 to 2016, Alvogen Group, Inc., as Chief Executive Officer from 2008 to 2013, Clarmin Explorations, Inc., as Chief Executive Officer, Tedor Pharma, Inc., as President & Chief Executive Officer, Cypress Pharmaceuticals, Inc., as Director, Forest Laboratories, Inc., as Principal, Zoetis Products LLC, as Vice President, Actavis Group hf, as Vice President-Mergers & Acquisitions from 2004 to 2008, and Alkensa, Inc., as Executive Vice President-Corporate Development.
Mr. Drysdale received his undergraduate degree in 1992 from the University of East Anglia.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CYBIN, INC.
0.01% | 2024-05-04 | 38,000 ( 0.01% ) | 13 148 $ | 2024-04-29 |
Douglas Drysdale active positions
| Companies | Position | Start |
|---|---|---|
| CYBIN INC. | Chief Executive Officer | 2020-07-31 |
Cybin Corp.
 Cybin Corp. Medical DistributorsDistribution Services Cybin Corp. engages in psychedelic drug development, unique delivery mechanisms, improved novel compounds and protocols that target psychiatric and neurological conditions. The company was founded by Paul Glavine, Eric So, and John Kanakis and is headquartered in Toronto, Canada. | Chief Executive Officer | 2020-08-31 |
SpineThera, Inc.
 SpineThera, Inc. BiotechnologyHealth Technology SpineThera, Inc. engages in the designs and development of injectable drugs to meet the requirements for administration in and near the spine. Its product include SX600, an investigational drug. The company was founded by Jeffrey Missling and is headquartered in Plymouth, MN. | Director/Board Member | 2022-05-15 |
Adelia Therapeutics, Inc.
 Adelia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adelia Therapeutics, Inc. operates as an biopharmaceutical company. The company was founded by Alex Nivorozhkin and Brett J. Greene in 2020 and is headquartered in Fitchburg, MA. | Director/Board Member | - |
Pernix Manufacturing LLC
 Pernix Manufacturing LLC Pharmaceuticals: MajorHealth Technology Pernix Manufacturing manufactures special pharmaceutical products. The company was founded on June 14, 2012 and is headquartered in Dallas, TX. | Chief Executive Officer | - |
Cybin IRL Ltd.
 Cybin IRL Ltd. Pharmaceuticals: MajorHealth Technology Cybin IRL Ltd. is a leading ethical biopharmaceutical company based in North Wall Quay, Ireland. The Irish company works with a network of world-class partners and internationally-recognized scientists to create safe and effective therapeutics for patients, specifically targeting a range of mental health issues. The CEO of the company is Douglas L. Drysdale. | Chief Executive Officer | - |
Former positions of Douglas Drysdale
| Companies | Position | End |
|---|---|---|
Tedor Pharma, Inc.
 Tedor Pharma, Inc. Pharmaceuticals: MajorHealth Technology Tedor Pharma, Inc. operates as a pharmaceutical company. It develops oral solid dose products. The firm offers development and manufacturing, formulation, laboratory, and analytical services. The company was founded in 2001 and is headquartered in Cumberland, RI. | Chief Executive Officer | 2020-06-30 |
| PERNIX THERAPEUTICS HOLDINGS INC | Chief Executive Officer | 2016-05-08 |
Alvogen Group, Inc.
 Alvogen Group, Inc. Pharmaceuticals: MajorHealth Technology Part of Alvogen, Inc., Alvogen Group, Inc. is a pharmaceutical company that offers a unique portfolio of high-quality and difficult-to-make pharmaceutical products. The company is based in Pine Brook, NJ. The company's targeted growth strategy is fueled by providing affordable generic medications that help reduce healthcare costs globally. | Chief Executive Officer | 2013-09-30 |
| ░░░░░░░ ░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Training of Douglas Drysdale
| University of East Anglia | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CYBIN INC. | Health Technology |
| Private companies | 15 |
|---|---|
Norwich Pharmaceuticals, Inc.
 Norwich Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Norwich Pharmaceuticals Inc. provides contract manufacturing and clinical services for the pharmaceuticals industry. It offers services, including clinical trial production support, quality assurance and control and regulatory compliance. The company was founded in 1887 and is headquartered in Norwich, NY. | Health Technology |
Actavis Group hf
 Actavis Group hf Pharmaceuticals: MajorHealth Technology Actavis Group hf develops, manufactures and sells generic pharmaceuticals. The company was founded in 1957 and is headquartered in Hafnarfjörður, Iceland. | Health Technology |
Zoetis Products LLC
 Zoetis Products LLC Pharmaceuticals: MajorHealth Technology Zoetis Products LLC engaged in the manufacturing of pharmaceutical products. The company was founded in 1975 and was headquartered in Florham Park, NJ. | Health Technology |
Forest Laboratories, Inc.
 Forest Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Forest Laboratories, Inc. is engaged in the development, manufacture, and sale of branded forms of drug products. Its products include Bystolic, which is used to decrease heart rate and myocardial contractility; Daliresp, which is used to reduce the risk of chronic obstructive pulmonary disease exacerbation; Linzess, which is used in the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation; and Namenda, which is used in the treatment of moderate to severe dementia. The company was founded in 1954 and is headquartered in New York, NY. | Health Technology |
| Alkensa, Inc. | |
Pernix Therapeutics Holdings, Inc.
 Pernix Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Pernix Therapeutics Holdings, Inc. engages in the research, development, and manufacture of biopharmaceutical products. It focuses on therapeutics for diseases on central nervous system, neurology, pain, and psychiatry. Its products include treatment of migraine pain and inflammation, insomnia, and depressive disorder. It distributes products through the following brands: Treximet, Silenor, and Zohydro ER with BeadTek. The company was founded in 1996 and is headquartered in Morristown, NJ. | Health Technology |
Pernix Manufacturing LLC
Pernix Manufacturing LLC Pharmaceuticals: MajorHealth Technology Pernix Manufacturing manufactures special pharmaceutical products. The company was founded on June 14, 2012 and is headquartered in Dallas, TX. | Health Technology |
Cypress Pharmaceuticals, Inc.
 Cypress Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cypress Pharmaceutical, Inc. develops, markets, and distributes prescription products to pharmaceutical wholesalers, chain drug stores, and other retail merchants in the United States. The company was founded on June 15, 1993 and is headquartered in Madison, MS. | Health Technology |
Cybin Corp.
Cybin Corp. Medical DistributorsDistribution Services Cybin Corp. engages in psychedelic drug development, unique delivery mechanisms, improved novel compounds and protocols that target psychiatric and neurological conditions. The company was founded by Paul Glavine, Eric So, and John Kanakis and is headquartered in Toronto, Canada. | Distribution Services |
Clarmin Explorations, Inc.
 Clarmin Explorations, Inc. Precious MetalsNon-Energy Minerals Clarmin Explorations, Inc. is an exploration company. The firm engages in the exploration and development of mineral properties. It holds interest in the Arlington property. The company was founded on October 13, 2016 and is headquartered in Toronto, Canada. | Non-Energy Minerals |
Tedor Pharma, Inc.
Tedor Pharma, Inc. Pharmaceuticals: MajorHealth Technology Tedor Pharma, Inc. operates as a pharmaceutical company. It develops oral solid dose products. The firm offers development and manufacturing, formulation, laboratory, and analytical services. The company was founded in 2001 and is headquartered in Cumberland, RI. | Health Technology |
Alvogen Group, Inc.
Alvogen Group, Inc. Pharmaceuticals: MajorHealth Technology Part of Alvogen, Inc., Alvogen Group, Inc. is a pharmaceutical company that offers a unique portfolio of high-quality and difficult-to-make pharmaceutical products. The company is based in Pine Brook, NJ. The company's targeted growth strategy is fueled by providing affordable generic medications that help reduce healthcare costs globally. | Health Technology |
Adelia Therapeutics, Inc.
Adelia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adelia Therapeutics, Inc. operates as an biopharmaceutical company. The company was founded by Alex Nivorozhkin and Brett J. Greene in 2020 and is headquartered in Fitchburg, MA. | Health Technology |
SpineThera, Inc.
SpineThera, Inc. BiotechnologyHealth Technology SpineThera, Inc. engages in the designs and development of injectable drugs to meet the requirements for administration in and near the spine. Its product include SX600, an investigational drug. The company was founded by Jeffrey Missling and is headquartered in Plymouth, MN. | Health Technology |
Cybin IRL Ltd.
Cybin IRL Ltd. Pharmaceuticals: MajorHealth Technology Cybin IRL Ltd. is a leading ethical biopharmaceutical company based in North Wall Quay, Ireland. The Irish company works with a network of world-class partners and internationally-recognized scientists to create safe and effective therapeutics for patients, specifically targeting a range of mental health issues. The CEO of the company is Douglas L. Drysdale. | Health Technology |
- Stock Market
- Insiders
- Douglas Drysdale
